113
Participants
Start Date
February 15, 2017
Primary Completion Date
November 12, 2020
Study Completion Date
November 12, 2020
Tocilizumab
6 Intravenous infusions of tocilizumab in a dosage of 8 mg/kg (or 4 mg/kg depending on biological results as mentioned by the SPC of Tocilizumab for the rheumatoid arthritis) every 4 weeks.
Placebo
6 Intravenous infusions of placebo every 4 weeks.
Hôpital européen, Marseille
CIC Besançon, Besançon
CHU Besançon, Besançon
CHRU Brest, Brest
Ch Des Pays de Morlaix, Morlaix
CHU Bordeaux, Bordeaux
CHU Rennes, Rennes
CHU Nantes, Nantes
CHU de Nancy, Nancy
CHRU de Strasbourg, Strasbourg
CH Le Mans, Le Mans
hôpital Sapêtrière -APHP, Paris
Hopital Nord service de rhumatologie-Franche Comté, Belfort
Centre hospitalier Sud-Francilien, Corbeil-Essonnes
CHU Dijon, Dijon
CH Mulhouse, Mulhouse
CHU St Etienne, Saint-Etienne
Roche Chugai
INDUSTRY
University Hospital, Brest
OTHER